Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-18 Purchase | 2024-09-19 8:21 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 125,000 | $0.75 | $93,750 | 11,440,865 (Indirect Direct) | View |
| 2024-05-20 Purchase | 2024-05-21 3:14 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 100,000 | $0.75 | $75,000 | 11,315,865 (Indirect Direct) | View |
| 2023-12-19 Purchase | 2023-12-20 2:05 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 150,000 | $0.5 | $75,000 | 11,215,865 (Indirect Direct) | View |
| 2023-08-01 Purchase | 2023-08-04 1:41 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 62,500 | $2 | $125,000 | 11,065,865 (Indirect Direct) | View |
| 2022-11-09 Sale | 2022-11-14 6:43 pm | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 162,500 | $1.5 | $243,750 | 1,975,358 (Direct) | View |
| 2022-04-29 Purchase | 2022-05-02 12:21 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 804,868 | $1 | $804,868 | 11,003,365 (Indirect Direct) | View |
| 2020-10-05 Purchase | 2022-04-26 9:24 pm | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 175,000 | $0.4 | $70,000 | 10,500,702 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-17 Option Award | 2024-07-22 6:58 pm | 2025-07-17 2034-07-17 | Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director | 40,000 | $0.33 | 40,000 (Direct) | View |
| 2024-07-17 Option Award | 2024-07-22 6:55 pm | 2025-07-17 2034-07-17 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 40,000 | $0.33 | 40,000 (Direct) | View |
| 2024-07-17 Option Award | 2024-07-22 6:50 pm | 2025-07-17 2034-07-17 | Nuo Therapeutics Inc. | AURX | Mintz Paul Director | 25,000 | $0.33 | 25,000 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-21 3:13 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 15,000 | $0.75 | 589,675 (Direct) | View |
| 2024-05-20 Option Award | 2024-05-21 3:11 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 135,000 | $0.75 | 5,178,345 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 2:04 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 20,000 | $0.5 | 574,948 (Direct) | View |
| 2023-12-19 Option Award | 2023-12-20 2:03 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 600,000 | $0.5 | 5,043,345 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:18 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 25,000 | $2 | 554,948 (Direct) | View |
| 2023-08-01 Option Award | 2023-08-03 4:17 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 100,000 | $2 | 4,443,345 (Direct) | View |
Ownership(A) | 2022-10-18 1:20 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 0 | $0 | 769,778 (Direct) | View |
| 2022-06-06 Option Award | 2022-06-15 6:18 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 275,000 | $0 | 275,000 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-02 12:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 10,532 | $1 | 2,137,858 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-02 12:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 25,000 | $1 | 529,948 (Direct) | View |
| 2022-04-29 Option Award | 2022-05-02 12:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 100,000 | $1 | 4,343,345 (Direct) | View |
Ownership | 2022-04-26 9:36 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 0 | $0 | 504,948 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:35 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | Mintz Paul Director | 101,666 | $0 | 101,666 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:34 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director | 111,666 | $0 | 111,666 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:32 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO | 43,328 | $0 | 43,328 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:31 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 133,334 | $0 | 133,334 (Direct) | View |
| 2022-03-04 Option Award | 2022-04-26 9:29 pm | 2022-03-04 2032-03-04 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 191,672 | $0 | 191,672 (Direct) | View |
Ownership | 2022-04-26 9:28 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 0 | $0 | 11,630,112 (Indirect) | View |
| 2021-12-30 Ownership | 2022-04-26 9:28 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,431,615 | $0 | 11,630,112 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:28 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 2,863,230 | $0 | 11,630,112 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:28 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,431,615 | $0.2 | 11,630,112 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 900,000 | $0 | 6,365,980 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:26 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-06 Ownership | 2022-04-26 9:26 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 322,635 | $0 | 6,365,980 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:26 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 900,000 | $0.2 | 6,365,980 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,137,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:25 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-01 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 4,562,596 (Direct) | View |
| 2021-12-06 Ownership | 2022-04-26 9:25 pm | 2021-12-01 2022-01-31 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 160,000 | $0 | 4,562,596 (Direct) | View |
| 2021-12-30 Ownership | 2022-04-26 9:25 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,137,635 | $0.2 | 4,562,596 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:24 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 302,205 | $0.4 | 10,500,702 (Direct) | View |
Ownership | 2022-04-26 9:24 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 0 | $0 | 10,500,702 (Indirect) | View |
| 2020-10-05 Ownership | 2022-04-26 9:24 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner | 1,596,615 | $0 | 10,500,702 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 45,000 | $0 | 4,565,980 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:23 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 1,222,635 | $0 | 4,565,980 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:23 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 407,545 | $0.4 | 4,565,980 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 45,000 | $0 | 2,287,326 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | 2020-10-05 2025-10-05 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 1,297,635 | $0 | 2,287,326 (Direct) | View |
| 2020-10-05 Ownership | 2022-04-26 9:22 pm | N/A N/A | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 432,545 | $0.4 | 2,287,326 (Direct) | View |
| 2019-11-15 Ownership | 2022-04-26 9:20 pm | 2019-11-15 2024-11-15 | Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner | 45,000 | $0 | 60,000 (Direct) | View |
| 2019-11-15 Ownership | 2022-04-26 9:18 pm | 2019-11-15 2024-11-15 | Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO | 45,000 | $0 | 60,000 (Direct) | View |